Appili Therapeutics (Appili Therapeutics) Total Stockholders Equity : $-7.33 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Total Stockholders Equity?

Appili Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-7.33 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Appili Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Appili Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2023 was -0.81.

Appili Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Appili Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Total Stockholders Equity Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

3.31

6.34

10.15

-2.58

-5.41

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															-3.94	-5.41	-6.60	-7.17	-7.33

Appili Therapeutics (OTCPK:APLIF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Appili Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-7.328	-	0)	/	121.266
	=	-0.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Appili Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.313	+	5.659)	/	-7.328
	=	-0.81

Appili Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.